Chugai signed a joint research and licencing agreement with Singapore-based biotechnology firm Gero to create new antibody drug candidates ...

Several medical organisations have filed a lawsuit against RFK Jr and the HHS over recent changes to the US immunisation schedule.

The pulmonary arterial hypertension market is forecast to grow at a CAGR of 2.0% from 2024 to 2034, reaching $9.35bn across 7MM.

GSK has concluded the acquisition of efimosfermin alfa, an investigational therapeutic for serious liver disease, from Boston Pharmaceuticals ...

The Swiss Agency for Therapeutic Products (Swissmedic) has approved Novartis’ Coartem (artemether-lumefantrine) Baby, described as the first malaria medicine for newborns and young infants. Known as ...

Alembic Pharmaceuticals has acquired UTILITY therapeutics, expanding its portfolio with the addition of Pivya to treat uUTIs.

The DoH and Children’s National Hospital in the US have signed a MoU to advance paediatric cell and gene therapy.

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...